Given the high expression of CCR2 (Figure 2H and Supplemental Figure 1B) and migration-related genes (Figure 2H) in NOD2-dependent LY6Clo I-NCMs, we hypothesized that signaling through CCL2/CCR2 plays a role in I-NCM–induced tumor regression. Here, CCL2 is linked to neoplasm.